Agilent Technologies Stock News

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.67 billion for the first quarter ended Jan. 31, 2022, an increase of 8% compared to the first quarter of 2021 and up 9% on a core(1) basis. On a GAAP basis, first-quarter net income was $283 million, or $0.93 per share. This compares with $288 million, or $0.93 per share, in the first quarter of fiscal year 2021. Non-GAAP(2) net income was $368 million, or $1.21 per share during the quarter, c

Agilent (A) delivered earnings and revenue surprises of 3.42% and 1.30%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?

Agilent Technologies (NYSE: A ) has outperformed the market over the past 5 years by 7.82% on an annualized basis. Buying $100 In A: 5 years ago, an investor could have purchased 1.93 shares of Agilent Technologies at the time with $100. This investment in A would have Full story available on Benzinga.com

Benzinga's after-hours earnings roundup aims to deliver quick details about a company's earnings report, its forward-looking guidance and any other notable details. The list is handpicked by the repor

SAN DIEGO--(BUSINESS WIRE)--Element Biosciences Partners with Agilent Technologies to Validate SureSelect Target Enrichment Panels on Elements AVITI System

Agilent Technologies (NYSE:A) is scheduled to announce Q1 earnings results on Tuesday, Feb. 22, after market close.The consensus EPS estimate is $1.18 (+11.3% Y/Y)

WASHINGTON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Epigenetics Market finds that increasing cancer rates may further expediting market growth. Primarily driven by increasing research activity and funding for Epigenetics, the total Global Epigenetics Market is estimated to reach USD 3.0 Billion by 2028. The market stood at a revenue of USD 0.8 Billion in the year 2021, and is expected to grow at a Compound Annual Growth Rate (CAGR) of 13.1%. Furthermore, the increasing personalized medication, and target therapy are also anticipated to augment the growth of the Global Epigenetics Market, states Vantage Market Research, in a report, titled " Epigenetics Market by Product (Instruments, Reagents & Kits, Others), by Application (Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases), by Technology (Methylation, Acetylation, Phosphorylation, Other Technologies), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

Agilent's (A) fiscal first-quarter results are expected to reflect strength across LSAG, ACG and DGG segments.

DUBLIN , Feb. 18, 2022 /PRNewswire/ -- The "Global Laboratory Consumables Market 2021" report has been added to ResearchAndMarkets.com''s offering. The Global Laboratory Consumables Market report is designed for general management, product managers and marketing executives in the laboratory consumables industry. For them, it provides up-to-date market data about those technologies in their areas of interest. and related markets. Information on specific segments or the whole industry can be used to evaluate markets, the competitive landscape, or identify opportunities and acquisition targets. A strategy for the consumables market must involve geographic market composition, market growth rate, and new competitors. This report saves time by providing comprehensive data in an easily readable format. Companies covered in the report include: Agilent Beckman Coulter Bio-Rad Danaher Eppendorf GE Healthcare Hitachi High Technologies Illumina Lonza … Full story available on Benzinga.com

Pune, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market report delivers a complete overview of key components like drivers, limitations, historic and current trends, technical development, and future growth. Research report contains company analysis, size, share, revenue and sales of the company, current advancements. Digital PCR and Real-Time PCR market analysis also focuses on the global key top industry players in the market, with details such as company profiles, capacity, production, price, cost, revenue. Get a Sample Copy of the Report at - https://www.absolutereports.com/enquiry/request-sample/20190575 The global Digital PCR and Real-Time PCR market size is projected to reach USD 1879.8 million by 2028, from USD 1180.1 million in 2021, at a CAGR of 6.8% during 2022-2028.  Polymerase chain reaction (PCR) is a laboratory technique performed commonly to amplify DNA, thereby producing many copies of a particular section of DNA in interest.

NVIDIA's (NVDA) fourth-quarter fiscal 2022 results reflect benefits of higher demand for chips used in data centers and gaming consoles amid the work-and-learn-at-home and gaming waves.

Cisco's (CSCO) fiscal second-quarter results reflect strength across the customer markets and revenue growth in all geographies.

The Trade Desk's (TTD) fourth-quarter results reflect gains from solid customer retention and a growing partner ecosystem.

Fastly's (FSLY) fourth-quarter 2021 revenues improve from the addition of new customers and the Computer@edge platform.

Shopify's (SHOP) fourth-quarter 2021 results benefit from the addition of new merchants.